UPDATED Apr 22, 2024
High return on equity, past performance and sound balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CBT | US$92.01 | -1.1% | 23.1% | US$5.1b | US$95.33 | PE11.8x | S4.8% | 1.7% | ||
MCEM | US$184.50 | 0% | 61.8% | US$677.4m | n/a | PE9.2x | n/a | 1.6% | ||
NEU | US$586.34 | -1.4% | 58.1% | US$5.6b | US$651.00 | PE14.5x | E-7.2% | 1.7% | ||
EUBG | US$0.33 | 0% | 43.5% | US$561.4m | n/a | PE246x | n/a | n/a | ||
DRD | US$8.55 | 2.0% | -20.6% | US$736.6m | US$13.25 | PE10.5x | n/a | 5.2% | ||
KNGW | US$0.32 | 0% | n/a | US$32.6m | n/a | PE24.2x | n/a | n/a |